Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X9RN
|
|||
| Former ID |
DNCL002355
|
|||
| Drug Name |
Robatumumab
|
|||
| Drug Type |
Monoclonal antibody
|
|||
| Indication | Colorectal cancer [ICD-11: 2B91.Z] | Discontinued in Phase 2 | [1] | |
| Osteosarcoma [ICD-11: 2B51] | Discontinued in Phase 2 | [1] | ||
| Sarcoma [ICD-11: 2A60-2C35] | Discontinued in Phase 2 | [1] | ||
| Company |
Merck
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027277) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.